Soleno Therapeutics Inc (NASDAQ: SLNO) established initial surge of 2.71% at $74.23, as the Stock market unbolted on Thursday, before settling in for the price of $72.27 at the close. Taking a more long-term approach, SLNO posted a 52-week range of $36.93-$74.50.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that the giant of the Healthcare sector posted annual sales growth of 0.00% over the last 5 years. Meanwhile, its Annual Earning per share during the time was 20.19%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 34.73%. This publicly-traded company’s shares outstanding now amounts to $45.70 million, simultaneously with a float of $36.40 million. The organization now has a market capitalization sitting at $3.70 billion. At the time of writing, stock’s 50-day Moving Average stood at $56.07, while the 200-day Moving Average is $51.32.
Soleno Therapeutics Inc (SLNO) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Soleno Therapeutics Inc industry. Soleno Therapeutics Inc’s current insider ownership accounts for 20.63%, in contrast to 92.23% institutional ownership. According to the most recent insider trade that took place on Apr 01 ’25, this organization’s insider sold 3,782 shares at the rate of 70.11, making the entire transaction reach 265,156 in total value, affecting insider ownership by 27,036.
Soleno Therapeutics Inc (SLNO) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
Soleno Therapeutics Inc’s EPS increase for this current 12-month fiscal period is 34.73% and is forecasted to reach 0.37 in the upcoming year.
Soleno Therapeutics Inc (NASDAQ: SLNO) Trading Performance Indicators
Let’s observe the current performance indicators for Soleno Therapeutics Inc (SLNO). It’s Quick Ratio in the last reported quarter now stands at 15.68. The Stock has managed to achieve an average true range (ATR) of 4.25.
In the same vein, SLNO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -4.26, a figure that is expected to reach -0.97 in the next quarter, and analysts are predicting that it will be 0.37 at the market close of one year from today.
Technical Analysis of Soleno Therapeutics Inc (SLNO)
Now, what If we examine the latest scores posted by [Soleno Therapeutics Inc, SLNO]. During the last 5-days, its volume was lower the volume of 1.07 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 93.01% While, its Average True Range was 4.12.
Raw Stochastic average of Soleno Therapeutics Inc (SLNO) in the period of the previous 100 days is set at 99.18%, which indicates a major rise in contrast to 98.46% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 91.00% that was higher than 77.05% volatility it exhibited in the past 100-days period.
